DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+14.78%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$112M
AUM Growth
+$112M
(+11%)
Cap. Flow
+$1.95M
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
46.21%
Holding
94
New
5
Increased
13
Reduced
15
Closed
17
Top Buys
| 1 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$4.16M |
| 2 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$3.93M |
| 3 |
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
|
$2.21M |
| 4 |
Galapagos
GLPG
|
$1.78M |
| 5 |
LOXO
Loxo Oncology, Inc
LOXO
|
$1.42M |
Top Sells
| 1 |
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
|
$4.35M |
| 2 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$2.63M |
| 3 |
OTIC
Otonomy, Inc.
OTIC
|
$1.99M |
| 4 |
XNPT
XENOPORT, INC.
XNPT
|
$1.63M |
| 5 |
Protalix BioTherapeutics
PLX
|
$1.41M |
Sector Composition
| 1 | Healthcare | 75.15% |
| 2 | Financials | 0.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADXS
76
DELISTED
Advaxis, Inc.
ADXS
| – | – |
-333
| Closed | -$51K |
|
|
OTIC
77
DELISTED
Otonomy, Inc.
OTIC
| – | – |
-111,466
| Closed | -$1.99M |
|
|
APTO
78
DELISTED
Aptose Biosciences, Inc.
APTO
| – | – |
-43
| Closed | -$83K |
|
|
ICPT
79
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – |
-2,430
| Closed | -$403K |
|
|
80
Protalix BioTherapeutics
PLX
$128M
| – | – |
-119,319
| Closed | -$1.41M |
|
81
Gilead Sciences
GILD
$140B
| – | – |
-5,700
| Closed | -$560K |
|
82
Corbus Pharmaceuticals
CRBP
$121M
| – | – |
-1,667
| Closed | -$79K |
|
83
Actinium Pharmaceuticals
ATNM
$53.3M
| – | – |
-3,000
| Closed | -$159K |
|
|
CELG
84
DELISTED
Celgene Corp
CELG
| – | – |
-5,200
| Closed | -$562K |
|
85
Amgen
AMGN
$153B
| – | – |
-3,700
| Closed | -$512K |
|